Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 3930-83-4 | MDL No. : | MFCD00099248 |
Formula : | C7H6INO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YEOYYWCXWUDVCX-UHFFFAOYSA-N |
M.W : | 247.03 | Pubchem ID : | 77529 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 47.25 |
TPSA : | 43.09 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.15 cm/s |
Log Po/w (iLOGP) : | 1.47 |
Log Po/w (XLOGP3) : | 0.93 |
Log Po/w (WLOGP) : | 1.39 |
Log Po/w (MLOGP) : | 2.11 |
Log Po/w (SILICOS-IT) : | 1.95 |
Consensus Log Po/w : | 1.57 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.34 |
Solubility : | 1.14 mg/ml ; 0.00462 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.42 |
Solubility : | 9.37 mg/ml ; 0.0379 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.94 |
Solubility : | 0.282 mg/ml ; 0.00114 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.38 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
41% | With potassium carbonate; copper(II) iodide In dimethyl sulfoxide at 110℃; for 4 h; Inert atmosphere | General procedure: A two-neck round bottom flask was charged with amagnetic stirrer, evacuated and backfilled with argon. 2-iodobenzamide ( 0.5mmol, 124 mg), aniline or α-substituted benzylamine (1.0 mmol), K2CO3(1.0 mmol, 138 mg) and CuBr2 (0.05mmol, 11 mg) in DMSO (5 mL) under argon atmosphere. The mixture was allowed tostir under argon atmosphere at 110 C for 4 h.The mixture was concentrated with the aid of a rotary evaporator, and theresidue was purified by column chromatography on silica gel using petroleumether/ethyl acetate (2:1) as eluent to provide the product 2-9. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With Triethoxysilane; [(2,5-F2C6H2-CH=N-C10H6)Co(III)(H)(PMe3)2] In tetrahydrofuran at 60℃; for 24 h; Schlenk technique | General procedure: To a 25 mL Schlenk tube containing a solution of 2 in 2 mL of THF was added amide (1.0 mmol) and (EtO)3SiH (0.50 g, 3.0 mmol). The reaction mixture was stirred at 60 °C until there was no amide left (monitored by TLC and GC–MS). The product was purified according to literature procedures by Beller |
71% | With Triethoxysilane; [cis-Fe(H)(SPh)(PMe3)4] In tetrahydrofuran at 60℃; for 24 h; Inert atmosphere | General procedure: To a 25ml Schlenk tube containing a solution of 1 in 2ml of THF was added amide (1.0 mmol) and (EtO)3SiH (0.50 g, 3.0 mmol). The reaction mixture was stirred at 60 °C until there was no amide left (monitored by TLC and GC-MS). The product was purified according to literature procedures by Beller [27]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With hydrogenchloride In sodium hydroxide; diethyl ether | EXAMPLE 2 [125 ](R)-N-[(1-Ethyl-2-pyrrolidinyl)-5-iodo-2-methoxybenzamide A solution of (R)-N-[(1-ethyl-2-pyrrolidinyl)methyl[-2-methoxy-5-tri-n-butyltinbenzamide (15 μg, 22 nmol) in diethylether (10 μL) was mixed with 10.4 mCi of Na125 I (3.2 μg, 22 nmol) in 0.001N NaOH (29 μL). Hydrochloric acid (0.1N, 10 μL) was added followed by the addition of an aqueous solution (5 μL) of sodium N-chloro-4-methylbenzene sulfonamide (16 μg, 70 nmol). After 10 min. at 20° C., NaOH (2N, 20 μL) was added. Extraction with ether (2*150 μL) gave 7.2 mCi of the desired iodobenzamide. Specific activity 590 Ci/mmol, radiochemical yield 70percent. |
[ 861118-00-5 ]
3,5-Diiodo-4-methylbenzaldehyde
Similarity: 0.69